Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study

Overview of attention for article published in Journal of Clinical Oncology, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 5 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 158 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 7,762 followers.

2012年の論文では RTのほうが未治療経過観察よりPFS悪いって治療前に調べてたら経過観察選んで今ごろGBかRBだったかもな https://t.co/za2wVyMYPa

@Eddie_Cliff @AaronGoodman33 @belinda_campbe https://t.co/PVRlYHA8eS Some use this LymphoCare study as an argument against the use of radiotherapy (or any treatment) in stage I patients. While PFS benefit to more intensive treatment, no difference in O…

JCO。第Ⅰ期濾胞性リンパ腫に対する初回治療。PFSはリツキシマブ併用化学療法、化学療法＋放射線の集学的治療では、各々放射線単独(HR 0.36、0.11)、無治療(HR 0.35、0.10)に比して良好。リツキシマブ単独とは有意差なし。 http://t.co/3eQjgkut

The standard #XRT alone for Stage I foll #lymphoma: prob not best anymore http://t.co/zZEXn5Ts

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.